"Frankston Hospital is the major provider of acute secondary and tertiary hospital services on the Mornington Peninsula. With 454 beds, it provides general and specialty medical and surgical services, mental health, maternity, and paediatric services. In its role as a major teaching centre, the hospital has affiliations with Monash University and Deakin University and links with other universities in postgraduate studies. During your stay with us it is possible some of your day-to-day care will be undertaken by doctors in-training, under supervision of senior medical staff. Some of your care and treatment may also be undertaken by nursing or allied health students under supervision."

During the past decade, Frankston Hospital conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 21 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 11 clinical trials were completed. i.e. 122.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Frankston Hospital" #1 sponsor was "Australian and New Zealand Intensive Care Research Centre" with 5 trials, followed by "Celgene" with 5 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Australasian Gastro-Intestinal Trials Group" with 3 trials sponsored and "Bayside Health" with 3 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Frankston Hospital" #1 collaborator was "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 3 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 2 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 2 trials as a collaborator and "Baxter Healthcare Corporation" with 2 trials as a collaborator. Other collaborators include 86 different institutions and companies that were collaborators in the rest 92 trials.

According to Clinical.Site data, the most researched conditions in "Frankston Hospital" are "Breast Cancer" (5 trials), "Critical Illness" (4 trials), "Multiple Myeloma" (4 trials), "Ovarian Cancer" (4 trials) and "Chronic Lymphocytic Leukemia" (3 trials). Many other conditions were trialed in "Frankston Hospital" in a lesser frequency.

Most popular intervention types in "Frankston Hospital" are "Drug" (60 trials), "Other" (10 trials), "Biological" (5 trials), "Procedure" (5 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Paclitaxel" (5 trials), "Cyclophosphamide" (4 trials), "Docetaxel" (4 trials) and "Rituximab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Frankston Hospital" are 64 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Frankston Hospital". undefined are not yet recruiting, 10 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Frankston Hospital, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Frankston Hospital, 2 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".